Another solution is offered to reduce and prevent the spread of SARS-Covid-2
Pierre Kory, M.D., Associate Professor of Medicine at St. Luke's Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II."
The drug referred to is Ivermectin. Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2)
Of course this is only supported by published research papers backed by scientific data and supported by a range of specialists in their fields and has the potential to save thousands of lives.
The big question is whether Microsoft co-founder Bill Gates approves. Apparently we get our medical recommendations from computer software engineers now. That makes sense.
